<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), a hematopoietic disorder for which formal tracking began as recently as 2001, is rapidly gaining recognition as a cause of <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> increases with age and is considered the most common <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic cancer</z:e> in the elderly </plain></SENT>
<SENT sid="2" pm="."><plain>The disease can follow an indolent course or rapidly progress to <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Comorbidities and functional issues make this disease challenging to diagnose and treat in geriatric patients </plain></SENT>
<SENT sid="4" pm="."><plain>This article reviews the epidemiology, classification, and treatment options for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>